Abbott LaboratoriesABTNYSE
Loading
Net Income ContractionContracting
Percentile Rank79
3Y CAGR-2.0%
5Y CAGR+7.7%
Year-over-Year Change
Total earnings after all expenses, taxes, and interest
3Y CAGR
-2.0%/yr
vs +30.8%/yr prior
5Y CAGR
+7.7%/yr
Recent deceleration
Acceleration
-32.8pp
Decelerating
Percentile
P79
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $6.52B | -51.3% |
| 2024 | $13.40B | +134.2% |
| 2023 | $5.72B | -17.5% |
| 2022 | $6.93B | -2.0% |
| 2021 | $7.07B | +57.3% |
| 2020 | $4.50B | +21.9% |
| 2019 | $3.69B | +55.7% |
| 2018 | $2.37B | +396.4% |
| 2017 | $477.00M | -65.9% |
| 2016 | $1.40B | - |